Accordingly, Barosi et al. concluded that JAK2 V617F homozygosity was independently associated with worse splenomegaly, higher white blood cell counts, aquagenic pruritus, and more frequent requirement for cytoreductive therapies in a study of 304 patients with PMF [72]. This evidence concerns the gene JAK2 and Splenomegaly.